Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:endDate |
2013
|
| gptkbp:fullName |
HIV Vaccine Trials Network 505
|
| https://www.w3.org/2000/01/rdf-schema#label |
HVTN 505
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:participants |
2504
|
| gptkbp:period |
Phase IIb
|
| gptkbp:reasonForStopping |
ineffective at preventing HIV infection
|
| gptkbp:result |
prevention of HIV infection
|
| gptkbp:secondaryOutcome |
reduction in viral load
|
| gptkbp:sponsor |
gptkb:National_Institute_of_Allergy_and_Infectious_Diseases
|
| gptkbp:startDate |
2009
|
| gptkbp:status |
stopped early
|
| gptkbp:studiedBy |
HIV vaccine
|
| gptkbp:targetAudience |
gptkb:men_who_have_sex_with_men
transgender women |
| gptkbp:vaccineType |
DNA/rAd5 vaccine
|
| gptkbp:bfsParent |
gptkb:HIV_Vaccine_Trials_Network
|
| gptkbp:bfsLayer |
7
|